Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (291-300 of 359) with videos related to

Pageof 36
Sort By:
Acta Neuropathologica|March 16, 2019
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitabilityRita Cacace, Bavo Heeman, Sara Van Mossevelde, et al.
Plos Medicine|August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control studyHana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
The Lancet. Neurology|May 23, 2014
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteriaBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Computers in Biology and Medicine|May 18, 2024
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's diseaseAlicia Gómez-Pascual, Talel Naccache, Jin Xu, et al.
Science Translational Medicine|July 4, 2014
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisGernot Kleinberger, Yoshinori Yamanishi, Marc Suárez-Calvet, et al.
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Brain : a Journal of Neurology|July 30, 2015
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjectsJon B Toledo, Henrik Zetterberg, Argonde C van Harten, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Pageof 36

Showing results (291-300 of 359) with videos related to

Sort By:
Pageof 36
Acta Neuropathologica|March 16, 2019
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitabilityRita Cacace, Bavo Heeman, Sara Van Mossevelde, et al.
Plos Medicine|August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control studyHana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
The Lancet. Neurology|May 23, 2014
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteriaBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Computers in Biology and Medicine|May 18, 2024
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's diseaseAlicia Gómez-Pascual, Talel Naccache, Jin Xu, et al.
Science Translational Medicine|July 4, 2014
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisGernot Kleinberger, Yoshinori Yamanishi, Marc Suárez-Calvet, et al.
The Lancet. Neurology|December 14, 2011
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyIlse Gijselinck, Tim Van Langenhove, Julie van der Zee, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Brain : a Journal of Neurology|July 30, 2015
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjectsJon B Toledo, Henrik Zetterberg, Argonde C van Harten, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Pageof 36